中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2013年
4期
42-43
,共2页
剖宫产术后%再次妊娠%阴道试产%再次剖宫产
剖宮產術後%再次妊娠%陰道試產%再次剖宮產
부궁산술후%재차임신%음도시산%재차부궁산
after cesarean%section pregnancy vaginal trial production%the second cesarean section
目的探讨剖宫产术后再次妊娠的分娩方式.方法回顾性分析了2010年2月-2012年5月我院收治的48例剖宫产术后再次妊娠的产妇的临床资料及分娩方式.结果本组48例产妇中,20例行阴道试产,试产成功14例,成功率70%.试产失败6例急诊行再次剖宫产,总共34例再次剖宫产.阴道分娩组与再次剖宫产组吸入性肺炎、肺不张、新生儿窒息等情况及新生儿Apgar评分均无明显差异(P>0.05);但再次剖宫产组的产后大出血、产褥感染及产后出血量等均明显高于阴道分娩组,有统计学意义(P<0.05).结论剖宫产术后再次妊娠分娩并非是剖宫产绝对指征,符合试产条件者,严密监护下阴道试产是安全、可行的.
目的探討剖宮產術後再次妊娠的分娩方式.方法迴顧性分析瞭2010年2月-2012年5月我院收治的48例剖宮產術後再次妊娠的產婦的臨床資料及分娩方式.結果本組48例產婦中,20例行陰道試產,試產成功14例,成功率70%.試產失敗6例急診行再次剖宮產,總共34例再次剖宮產.陰道分娩組與再次剖宮產組吸入性肺炎、肺不張、新生兒窒息等情況及新生兒Apgar評分均無明顯差異(P>0.05);但再次剖宮產組的產後大齣血、產褥感染及產後齣血量等均明顯高于陰道分娩組,有統計學意義(P<0.05).結論剖宮產術後再次妊娠分娩併非是剖宮產絕對指徵,符閤試產條件者,嚴密鑑護下陰道試產是安全、可行的.
목적탐토부궁산술후재차임신적분면방식.방법회고성분석료2010년2월-2012년5월아원수치적48례부궁산술후재차임신적산부적림상자료급분면방식.결과본조48례산부중,20례행음도시산,시산성공14례,성공솔70%.시산실패6례급진행재차부궁산,총공34례재차부궁산.음도분면조여재차부궁산조흡입성폐염、폐불장、신생인질식등정황급신생인Apgar평분균무명현차이(P>0.05);단재차부궁산조적산후대출혈、산욕감염급산후출혈량등균명현고우음도분면조,유통계학의의(P<0.05).결론부궁산술후재차임신분면병비시부궁산절대지정,부합시산조건자,엄밀감호하음도시산시안전、가행적.
Objective To explore secondary pregnancy after cesarean section delivery mode. Methods a retrospective analysis of 2010 February to 2012 May in our hospital, 48 cases of secondary pregnancy after cesarean section on maternal clinical data and mode of delivery. Results the 48 cases of maternal, 20 routine vaginal trial production, production was successful in 14 cases, the success rate of 70%. Trial production of 6 cases failed emergency repeat cesarean section, a total of 34 cases of the second cesarean section. The vaginal delivery group and the second cesarean section group aspiration pneumonia, atelectasis, neonatal asphyxia and neonatal Apgar score showed no significant difference (P>0.05); but the second cesarean section group of postpartum hemorrhage, puerperal infection and bleeding were significantly higher than those in the vaginal delivery group, there was statistical significance (P<0.05). Conclusion secondary pregnancy after cesarean section delivery is not absolute indications for cesarean section, with trial production conditions, strict monitoring of vaginal delivery is safe, feasible.